4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-22-018942
President & CEO bought 144,666 shares at an average $1.94 ($280,943)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quinn Anthony G. President & CEO | 2022-03-11 | Purchase | +34,777 | $2.06 | $71,780 | 363,572 | D: show line 1 in the form |
| Quinn Anthony G. President & CEO | 2022-03-14 | Purchase | +67,472 | $1.93 | $130,221 | 431,044 | D: show line 2 in the form |
| Quinn Anthony G. President & CEO | 2022-03-15 | Purchase | +42,417 | $1.86 | $78,942 | 473,461 | D: show line 3 in the form |
| Open-market purchases · 144,666 sh · avg $1.94 · $280,943 | |||||||
Loading xslF345X03/doc4.xml…